Rare diseases
Investigational molecules
Locations
Back to France1 537 clinical trials in Toulon, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Bintrafusp Alfa and Doxorubicin Hydrochloride for Adults with Advanced Soft-Tissue Sarcoma
FranceStudy on Stopping Infliximab, Methotrexate, and Azathioprine in Patients with Sarcoidosis in Remission
FranceStudy on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma
FranceStudy on Improving Live Birth Rates in Women Under 37 with Infertility Using cpFT During ICSI
FranceStudy on Stopping and Restarting Acalabrutinib in Elderly Patients with Untreated Chronic Lymphocytic Leukemia (CLL)
FranceStudy on the Safety and Effectiveness of Azacitidine and Venetoclax for Untreated Higher-Risk Myelodysplastic Syndromes Not Eligible for Transplant
FranceStudy on Guselkumab for Healing in Crohn's Disease Patients
FranceStudy of ODM-208 (opevesostat) safety and effectiveness in patients with metastatic castration-resistant prostate cancer
FranceStudy on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment
FranceStudy on the Effects of Povetacicept for Adults with IgA Nephropathy
FranceStudy on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema
FranceStudy on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer treatments, including innovative combination therapies and immunotherapy approaches. Multiple studies evaluating novel drug combinations to improve patient outcomes.
Research spans various disease stages and includes both early-stage and metastatic cancer treatments.
Studies investigating treatments for chronic lymphocytic leukemia and blood-related conditions. Research includes evaluation of novel drug combinations and targeted therapies.
Focus on improving treatment outcomes for previously untreated patients with coexisting conditions.
Investigations into stroke prevention and treatment of thrombotic conditions. Studies evaluating new anticoagulants and therapeutic approaches for various cardiovascular conditions.
Clinical trials examining innovative treatments for atrial fibrillation and deep vein thrombosis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
